124 related articles for article (PubMed ID: 36428153)
1. Investigating the Dynamic Binding Behavior of PMX53 Cooperating with Allosteric Antagonist NDT9513727 to C5a Anaphylatoxin Chemotactic Receptor 1 through Gaussian Accelerated Molecular Dynamics and Free-Energy Perturbation Simulations.
Xiaoli A; Yuzhen N; Qiong Y; Yang L; Yao X; Bing Z
ACS Chem Neurosci; 2022 Dec; 13(23):3502-3511. PubMed ID: 36428153
[TBL] [Abstract][Full Text] [Related]
2. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
[TBL] [Abstract][Full Text] [Related]
3. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.
Robertson N; Rappas M; Doré AS; Brown J; Bottegoni G; Koglin M; Cansfield J; Jazayeri A; Cooke RM; Marshall FH
Nature; 2018 Jan; 553(7686):111-114. PubMed ID: 29300009
[TBL] [Abstract][Full Text] [Related]
4. Orthosteric and allosteric action of the C5a receptor antagonists.
Liu H; Kim HR; Deepak RNVK; Wang L; Chung KY; Fan H; Wei Z; Zhang C
Nat Struct Mol Biol; 2018 Jun; 25(6):472-481. PubMed ID: 29867214
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
[TBL] [Abstract][Full Text] [Related]
6. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models.
Benson MJ; Thomas NK; Talwar S; Hodson MP; Lynch JW; Woodruff TM; Borges K
Neurobiol Dis; 2015 Apr; 76():87-97. PubMed ID: 25681535
[TBL] [Abstract][Full Text] [Related]
7. Exploring the deactivation mechanism of human
Chen J; Wang J; Zeng Q; Wang W; Sun H; Wei B
Front Mol Biosci; 2022; 9():972463. PubMed ID: 36111136
[TBL] [Abstract][Full Text] [Related]
8. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
Front Immunol; 2020; 11():1789. PubMed ID: 32983087
[TBL] [Abstract][Full Text] [Related]
9. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
Hernandez MX; Namiranian P; Nguyen E; Fonseca MI; Tenner AJ
ASN Neuro; 2017 Feb; 9(1):1759091416687871. PubMed ID: 28078911
[TBL] [Abstract][Full Text] [Related]
10. Insights into the molecular mechanism of positive cooperativity between partial agonist MK-8666 and full allosteric agonist AP8 of hGPR40 by Gaussian accelerated molecular dynamics (GaMD) simulations.
An X; Bai Q; Bing Z; Liu H; Yao X
Comput Struct Biotechnol J; 2021; 19():3978-3989. PubMed ID: 34377364
[TBL] [Abstract][Full Text] [Related]
11. C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion.
Shi Y; Jin Y; Li X; Chen C; Zhang Z; Liu X; Deng Y; Fan X; Wang C
ACS Chem Neurosci; 2021 Nov; 12(21):3994-4006. PubMed ID: 34637270
[TBL] [Abstract][Full Text] [Related]
12. Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor.
Miao Y; McCammon JA
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12162-12167. PubMed ID: 27791003
[TBL] [Abstract][Full Text] [Related]
13. Effect of a C5a receptor antagonist on macrophage function in an intestinal transplant rat model.
Toyama C; Maeda A; Kogata S; Takase K; Kodama T; Masahata K; Ueno T; Kamiyama M; Tazuke Y; Eguchi H; Matsunami K; Miyagawa S; Okuyama H
Transpl Immunol; 2022 Jun; 72():101559. PubMed ID: 35227893
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
Venugopal PP; Das BK; Soorya E; Chakraborty D
Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
[TBL] [Abstract][Full Text] [Related]
15. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Pharmacodynamic Method to Assess Complement C5a Receptor Antagonist Efficacy.
Cui CS; Kumar V; Gorman DM; Clark RJ; Lee JD; Woodruff TM
ACS Pharmacol Transl Sci; 2022 Jan; 5(1):41-51. PubMed ID: 35059568
[TBL] [Abstract][Full Text] [Related]
17. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling.
Rana S; Sahoo AR; Majhi BK
Mol Biosyst; 2016 Apr; 12(5):1586-99. PubMed ID: 26978009
[TBL] [Abstract][Full Text] [Related]
18. Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking.
Tamamis P; Kieslich CA; Nikiforovich GV; Woodruff TM; Morikis D; Archontis G
BMC Biophys; 2014; 7():5. PubMed ID: 25170421
[TBL] [Abstract][Full Text] [Related]
19. Mapping of allosteric druggable sites in activation-associated conformers of the M2 muscarinic receptor.
Miao Y; Nichols SE; McCammon JA
Chem Biol Drug Des; 2014 Feb; 83(2):237-46. PubMed ID: 24112716
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Pharmacokinetics of Complement C5a Receptor Antagonists PMX53 and PMX205 in Mice.
Kumar V; Lee JD; Clark RJ; Noakes PG; Taylor SM; Woodruff TM
ACS Omega; 2020 Feb; 5(5):2345-2354. PubMed ID: 32064396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
